Tarsons Products Limited Stock Price Today (NSE: TARSONS)
Fundamental Score
Tarsons Products Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Tarsons Products Limited share price today is ₹302.30, down 0.28% on NSE/BSE as of 16 September 2026. Tarsons Products Limited (TARSONS) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹1.61K (Cr). The 52-week high for TARSONS share price is ₹375.00 and the 52-week low is ₹164.45. At a P/E ratio of 144.64x, TARSONS is currently trading above its industry average P/E of 36.70x. 0
Tarsons Products Limited Share Price Chart — NSE/BSE Historical Performance
Tarsons Products Limited share price chart: 3.72% return over the past month. 52-week high ₹375.00, 52-week low ₹164.45.
Tarsons Products Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹303.00 | ₹305.80 | ₹287.10 | ₹302.30 | 1.07L (Cr) | |
| ₹311.75 | ₹312.45 | ₹301.00 | ₹303.15 | 98.30K (Cr) | |
| ₹317.65 | ₹317.65 | ₹304.00 | ₹311.20 | 1.60L (Cr) | |
| ₹316.00 | ₹333.90 | ₹311.35 | ₹317.65 | 1.36L (Cr) | |
| ₹327.30 | ₹329.05 | ₹315.05 | ₹321.35 | 1.14L (Cr) | |
| ₹326.60 | ₹330.20 | ₹321.15 | ₹325.15 | 67.59K (Cr) | |
| ₹336.00 | ₹336.00 | ₹327.00 | ₹328.55 | 80.07K (Cr) | |
| ₹336.50 | ₹341.40 | ₹333.00 | ₹335.55 | 63.66K (Cr) | |
| ₹346.00 | ₹349.40 | ₹333.10 | ₹336.50 | 1.98L (Cr) | |
| ₹344.00 | ₹346.90 | ₹337.00 | ₹345.35 | 1.14L (Cr) |
Tarsons Products Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹330.00 | ₹349.40 | ₹287.10 | ₹302.30 | -8.39% | |
| ₹317.90 | ₹375.00 | ₹288.00 | ₹331.65 | +4.33% | |
| ₹266.05 | ₹334.90 | ₹259.70 | ₹314.60 | +18.25% | |
| ₹207.99 | ₹284.40 | ₹199.41 | ₹267.99 | +28.85% | |
| ₹219.92 | ₹257.50 | ₹198.24 | ₹209.46 | -4.76% | |
| ₹168.60 | ₹222.90 | ₹168.60 | ₹219.92 | +30.44% | |
| ₹186.00 | ₹207.85 | ₹164.45 | ₹166.46 | -10.51% | |
| ₹196.00 | ₹234.67 | ₹184.30 | ₹190.80 | -2.65% | |
| ₹235.17 | ₹237.00 | ₹192.30 | ₹194.10 | -17.46% | |
| ₹225.99 | ₹243.80 | ₹213.40 | ₹233.30 | +3.23% | |
| ₹290.00 | ₹292.00 | ₹198.00 | ₹225.45 | -22.26% | |
| ₹305.00 | ₹309.95 | ₹286.00 | ₹289.05 | -5.23% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Tarsons Products Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Tarsons Products Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TARSONS across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (39.56%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (20.66%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (13.04% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
10 factors identified
Below-Average Return on Equity (0.00%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.87%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 144.64x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-60.59%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-76.03% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-26.20% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (1.97x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-289.07 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.06%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Tarsons Products Limited vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Tarsons Products Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Tarsons Products LimitedTarsons Product...Selected✓ TARSONS • 543399 | 17.1/100 | ₹302.30₹302 | ₹1608.39₹1608.39 | 144.64Average 144.6 Average | 0.00%Poor 0.00% Poor | 4.87%Poor 4.87% Poor | 0.60Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Poly Medicure LimitedPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1724.00₹1724 | ₹17474.36₹17474.36 | 55.45Average 55.5 Average | 10.97%Average 10.97% Average | 14.28%Average 14.28% Average | 0.11Excellent 0.1 Excellent | 18.85%Excellent 18.85% Excellent | 18.98%Excellent 18.98% Excellent | 0.20% |
Fischer Medical Ventures LimitedFischer Medical... FISCHER • 524743 | 21.9/100 | ₹34.60₹35 | ₹2264.62₹2264.62 | 14.42Average 14.4 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.19Excellent 0.2 Excellent | — — | — — | 0.01% |
Laxmi Dental LimitedLaxmi Dental Li... LAXMIDENTL • 544339 | 69.6/100 | ₹201.14₹201 | ₹1105.47₹1105.47 | 35.54Average 35.5 Average | 12.83%Average 12.83% Average | 12.34%Average 12.34% Average | 0.00Excellent 0.0 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹369.90₹370 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹468.00₹468 | ₹610.20₹610.20 | 30.06Average 30.1 Average | 18.16%Good 18.16% Good | 24.15%Excellent 24.15% Excellent | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹387.00₹387 | ₹464.52₹464.52 | 20.38Average 20.4 Average | 18.60%Good 18.60% Good | 23.74%Excellent 23.74% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
Nureca LimitedNureca Limited... NURECA • 543264 | 16.5/100 | ₹334.00₹334 | ₹318.70₹318.70 | 77.67Average 77.7 Average | 0.00%Poor 0.00% Poor | 3.30%Poor 3.30% Poor | 0.00Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹151.80₹152 | ₹293.54₹293.54 | 30.79Average 30.8 Average | 10.45%Average 10.45% Average | 19.30%Good 19.30% Good | 0.65Good 0.7 Good | — — | — — | 0.45% | |
38.2/100 | ₹103.25₹103 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
32.1/100 | ₹150.00₹150 | ₹215.42₹215.42 | 23.96Average 24.0 Average | 11.99%Average 11.99% Average | 15.14%Good 15.14% Good | 0.03Excellent 0.0 Excellent | — — | — — | 0.00% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Limited share price17474.36 Cr
- Fischer Medical Ventures Limited share price2264.62 Cr
- Laxmi Dental Limited share price1105.47 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
- HSIL Limited share price610.20 Cr
Tarsons Products Limited PE Ratio History
Historical price-to-earnings ratio for TARSONS — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹5.60 | ₹233.30 | 41.7x |
| FY 2024 | ₹8.01 | ₹403.65 | 50.4x |
| FY 2023 | ₹15.17 | ₹527.30 | 34.8x |
| FY 2022 | ₹19.46 | ₹694.45 | 35.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Tarsons Products Limited Quarterly Performance
Latest quarterly metrics for TARSONS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
20.66%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-60.59%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
13.04%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-26.20%
Compounded annual net profit growth over 5 years
Tarsons Products Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for TARSONS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Tarsons Products Limited Financial Statements
Annual income statement, balance sheet and cash flow for Tarsons Products Limited (TARSONS) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Tarsons Products Limited
About TARSONS (Tarsons Products Limited)
Tarsons Products Ltd is a prominent Indian manufacturer specializing in the creation and distribution of high-quality laboratory plasticware. They offer a diverse catalog of produc...ts critical to scientific research and development, catering to a broad spectrum of applications within laboratories. The company's portfolio encompasses an array of essential items, carefully designed for precise and reliable use in various scientific procedures. From basic storage solutions to advanced consumables, Tarsons aims to provide researchers with the tools necessary to conduct experiments efficiently and accurately. Their commitment to quality materials and innovative designs underscores their dedication to supporting the scientific community. Tarsons' product line demonstrates a thorough understanding of the diverse needs of modern laboratories. Their offerings range from specialized containers for cell culture and cryopreservation to essential components for liquid handling and filtration. The meticulous design of their products considers factors like chemical compatibility, temperature resistance, and ease of use. Furthermore, the company recognizes the growing importance of genomics and PCR-based research, offering a comprehensive range of consumables optimized for these applications. By providing a wide selection of both disposable and reusable items, Tarsons strives to meet the varied requirements of different research settings, from academic institutions to industrial laboratories. Through a commitment to quality and a comprehensive product range, Tarsons Products Ltd plays a vital role in supporting the advancement of scientific discovery. Their products are integral to a multitude of research processes, offering scientists the tools they require to conduct experiments with precision and confidence. The company's unwavering focus on innovation and customer satisfaction solidifies its position as a trusted supplier of laboratory plasticware. Their reach extends beyond domestic markets, establishing Tarsons as a significant contributor to the global scientific community.
Company Details
Key Leadership
TARSONS Share Price: Frequently Asked Questions
What is the current share price of Tarsons Products Limited?
Tarsons Products Limited (TARSONS) trades at ₹302.30 on NSE and BSE. Market cap ₹1.61K (Cr). Educational data only.
What is the P/E ratio of Tarsons Products Limited?
Tarsons Products Limited has a P/E of 144.64x vs industry average 36.70x.
What is the Bull Run score for Tarsons Products Limited?
Tarsons Products Limited has a Bull Run score of 17.1/100 based on 25+ financial parameters.
Does Tarsons Products Limited pay dividends?
Tarsons Products Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Tarsons Products Limited?
Tarsons Products Limited has ROE of 0.00%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Tarsons Products Limited?
Tarsons Products Limited has debt-to-equity of 0.60.
Is Tarsons Products Limited a good investment?
Bull Run gives Tarsons Products Limited a score of 17.1/100. This is not investment advice — consult a SEBI-registered advisor.